There are two main types of chronic lymphocytic leukemia, and knowing whether a patient has the aggressive or the slow version is very important to determine treatment early on.

Leukemia can be very different from person to person, even within the same type of cancer. Scientists thought they understood how leukemia begins, but it may be more complicated than we thought.

If certain changes can cause a cell to become cancerous, reversing those changes should return the cell to normal. It may be simple, but it's not easy.

Figuring out the molecular puzzles that can change a healthy cell to a cancer cell would be difficult even if you could watch the process happen.

Traditionally a series of x-rays of all of the major bones in the body are used to detect myeloid myeloma , a process known as a radiographic skeletal survey. Yet in some areas, especially Europe, whole body CT is beginning to gain favor as testing indicates it is a more effective and thorough exam for measuring bone involvement in multiple myelomas , a bone-based form of leukemia. Ask your oncologist about whole body CT scanning for multiple myeloma . A formal comparison between the two imaging technologies was presented at the American Roentgen Ray Society's annual meeting by ...

Drug development is a tricky process, and it's common for pharmaceuticals to flounder initially before their best use is discovered.

After certain types of heart attacks, doctors often use stents to prop open the arteries. Another method that may be used involves removing blood clots through thrombus aspiration (TA), but studies have shown mixed long-term results.

Health Canada, the Canadian version of the U.S. Food & Drug Administration (FDA), has issued an alert regarding the medication  REVLIMID ( lenalidomide ) that's used to treat multiple myeloma .

Heart failure patients often take medication to lower their risk of stroke, hemorrhage or dying. A common choice is warfarin (Coumadin), though a large clinical trial has found that cheaper over-the-counter aspirin may be just as effective.

Patients are still receiving blood transfusions more often than needed, and a new study suggests premature or unnecessary transfusions could be leading to worse outcomes.